arrow
C

Christoph Oing

newcastle university
H指数:32
被引数:4,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines

欧洲泌尿外科学会睾丸癌指南:2026版指南摘要

2026-04-270
PRE
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis

基于疾病体积的转移性激素敏感型前列腺癌最佳治疗方法: 系统评价和网络荟萃分析

2025-11-170
OA
Oncology professionals' perceptions and recommendations to improve well-being and health at work in times of crisis: qualitative thematic analysis from the ESMO Resilience Task Force survey series

肿瘤学专业人士对危机时期改善工作场所福祉和健康的看法与建议:来自ESMO韧性工作组调查系列的质性主题分析

2025-03-010
OAAI
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends Survey

重新定义预后良好型精原细胞瘤:更新后的国际生殖细胞癌协作组分类对临床实践的影响及SEMITrends调查结果

2025-02-050
PRE
Oncologists' voices in time of crisis: Findings from the ESMO Resilience Task Force survey series on how members can be helped and supported e A qualitative analysis

危机时期肿瘤科医生的声音:ESMO韧性工作组系列调查的结果,探讨如何帮助和支持成员——一项定性分析

2024-09-010
PRE
Characteristics and palliative management of patients with cisplatin-refractory germ cell tumours: A Global Germ Cell Cancer Collaborative Group (G3) retrospective registry study

顺铂耐药性生殖细胞肿瘤患者的特点与姑息管理:全球生殖细胞癌协作组(G3)回顾性登记研究

2024-09-010
PRE
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis

PARP抑制剂和雄激素受体信号抑制剂联合治疗转移性前列腺癌: 定量合成和荟萃分析

2024-04-0110
OA